octapharmausa.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /_common/locations/ Disallow: /errorpages/404 Disallow: /errorpages/generic Disallow: /search/ Sitemap: | ||
Meta Tags
| Title | Octapharma |
| Description | NUWIQ PUP Octapharma - It’s in our |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.157.103.84 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
octapharmausa.com Valuation
|
US$121,788,844
Last updated: 2023-05-04 05:28:28
octapharmausa.com has Semrush global rank of 86,907. octapharmausa.com has an estimated worth of US$ 121,788,844, based on its estimated Ads revenue. octapharmausa.com receives approximately 14,052,559 unique visitors each day. Its web server is located in United States, with IP address 52.157.103.84. According to SiteAdvisor, octapharmausa.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$121,788,844 |
| Daily Ads Revenue | US$112,421 |
| Monthly Ads Revenue | US$3,372,615 |
| Yearly Ads Revenue | US$40,471,370 |
| Daily Unique Visitors | 936,838 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| octapharmausa.com. | A | 3599 | IP: 52.157.103.84 |
| octapharmausa.com. | NS | 3600 | NS Record: ns5.netnames.net. |
| octapharmausa.com. | NS | 3600 | NS Record: ns6.netnames.net. |
| octapharmausa.com. | NS | 3600 | NS Record: ns1.netnames.net. |
| octapharmausa.com. | NS | 3600 | NS Record: ns2.netnames.net. |
| octapharmausa.com. | MX | 3600 | MX Record: 5 mx08-005e3e01.pphosted.com. |
| octapharmausa.com. | MX | 3600 | MX Record: 5 mx07-005e3e01.pphosted.com. |
| octapharmausa.com. | TXT | 3600 | TXT Record: kdwcz61d690wbmzynwykf0tl27xqnjgl |
| octapharmausa.com. | TXT | 3600 | TXT Record: v=spf1 ip4:94.230.213.50 include:spf-005e3e01.pphosted.com -all |
| octapharmausa.com. | TXT | 3600 | TXT Record: x9ZHhr06uStWnAVzxoJcLZ82SgEwotEofyFiCyh3M42CG9Pdne3aVEh8CXz7rep8cW08FH+JPVviyj0gwa+I5g== |
| octapharmausa.com. | TXT | 3600 | TXT Record: dx2ntw58c0416jz3brc29sknrrn9q2g8 |
| octapharmausa.com. | TXT | 3600 | TXT Record: google-site-verification=zvts54ZJUviP-mIPrfP8oMZUCazofXnM0k3BgU4vbU8 |
HtmlToTextCheckTime:2023-05-04 05:28:28
| USA About us Plasma Products Engagement News Careers NUWIQ PUP Study The largest prospective clinical trial of a single FVIII product in previously untreated patients with hemophilia A. Review the NuProtect Study and Findings News & stories Check out our latest stories 2023-03-22 Press release Octapharma USA Grant Supports PANS/PANDAS Education Event at NHIA Conference March 27 in Washington, D.C. 2023-03-06 Press release Octapharma USA Research at AAAAI: cutaquig® Study at Higher Infusion Rates Presented 2023-02-21 Press release Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement 2023-02-20 Corporate news Octapharma Group delivers strong growth in sales and operating income in 2022 Show more Patient engagement Octapharma takes an active role in our community We sponsor and support organizations worldwide. Learn how we engage with patients Our products Products Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders. |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Tue, 26 Oct 2021 08:01:42 GMT Server: Apache Location: https://www.octapharmausa.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 cache-control: s-maxage=60, stale-while-revalidate content-security-policy: upgrade-insecure-requests content-type: text/html; charset=utf-8 date: Tue, 26 Oct 2021 08:01:42 GMT etag: "5685b-13F5oNLgdJNimDuL8tA0+YiIBs4" referrer-policy: no-referrer-when-downgrade server: Apache strict-transport-security: max-age=15638400; includeSubDomains x-content-type-options: nosniff x-frame-options: allow-from https://app.storyblok.com/ x-powered-by: Next.js x-sm-scope: us x-xss-protection: 1; mode=block content-length: 354395 |
octapharmausa.com Whois Information
Domain Name: OCTAPHARMAUSA.COM Registry Domain ID: 98551733_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-05-26T05:17:47Z Creation Date: 2003-05-30T12:56:48Z Registry Expiry Date: 2022-05-30T12:56:48Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: NS1.NETNAMES.NET Name Server: NS2.NETNAMES.NET Name Server: NS5.NETNAMES.NET Name Server: NS6.NETNAMES.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T08:49:06Z <<< |